Mitral valve repair for bacterial endocarditis

W. G. Hendren, A. S. Morris, Eliot Rosenkranz, B. W. Lytle, P. C. Taylor, W. J. Stewart, F. D. Loop, D. M. Cosgrove

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Twenty-two patients with mitral insufficiency resulting from native valve endocarditis underwent mitral valve repair. Six patients had acute endocarditis with positive blood cultures and active valve infection. Sixteen patients were cured of active infection, but mitral insufficiency developed as a result of prior infection. Mean age was 48.5 ± 21.7 years; 13 (59%) were male. Mean New York Heart Association functional class was 2.6 ± 1.2. Multiple valve lesions were present in 11 (50%) patients. Valve abnormalities included leaflet perforation in 13 patients, chordal rupture or elongation in 14, vegetations in 5; and annular abscess in 1. In patients with acute endocarditis all macroscopically infected tissue was excised. Multiple techniques were required to achieve valve competence. Suture or patch closure of perforation was done in 14 patients, chordal shortening or transfer in 9, leaflet resection and closure in 4, leaflet resection with pericardial patching in 5, and annuloplasty in 15. Mitral valvuloplasty was combined with other procedures in 11 (50%) patients. There were two (9%) hospital deaths, both occurring in patients with healed endocarditis. There was one (9%) death in a patient undergoing an isolated procedure and one (9%) in a patient undergoing a combined procedure. Mean follow-up was 24 ± 16.8 months and was complete. Seventeen (85%) were in New York Heart Association functional class I, and three (15%) were in class II. There were no late deaths, reoperations, recurrent endocarditis, thromboembolic events, or other valve-related morbidity. We conclude that mitral valve repair for insufficiency resulting from bacterial endocarditis (1) is possible in acute and healed disease, (2) has a low operative mortality, and (3) has resulted in patients free of recurrent infection and valve-related morbidity and mortality. Mitral valve repair is an attractive alternate to valve replacement in bacterial endocarditis.

Original languageEnglish
Pages (from-to)124-129
Number of pages6
JournalJournal of Thoracic and Cardiovascular Surgery
Volume103
Issue number1
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Bacterial Endocarditis
Mitral Valve
Endocarditis
Mitral Valve Insufficiency
Infection
Morbidity
Mortality
Acute Disease
Reoperation
Mental Competency
Abscess
Sutures
Rupture

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Hendren, W. G., Morris, A. S., Rosenkranz, E., Lytle, B. W., Taylor, P. C., Stewart, W. J., ... Cosgrove, D. M. (1992). Mitral valve repair for bacterial endocarditis. Journal of Thoracic and Cardiovascular Surgery, 103(1), 124-129.

Mitral valve repair for bacterial endocarditis. / Hendren, W. G.; Morris, A. S.; Rosenkranz, Eliot; Lytle, B. W.; Taylor, P. C.; Stewart, W. J.; Loop, F. D.; Cosgrove, D. M.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 103, No. 1, 01.01.1992, p. 124-129.

Research output: Contribution to journalArticle

Hendren, WG, Morris, AS, Rosenkranz, E, Lytle, BW, Taylor, PC, Stewart, WJ, Loop, FD & Cosgrove, DM 1992, 'Mitral valve repair for bacterial endocarditis', Journal of Thoracic and Cardiovascular Surgery, vol. 103, no. 1, pp. 124-129.
Hendren WG, Morris AS, Rosenkranz E, Lytle BW, Taylor PC, Stewart WJ et al. Mitral valve repair for bacterial endocarditis. Journal of Thoracic and Cardiovascular Surgery. 1992 Jan 1;103(1):124-129.
Hendren, W. G. ; Morris, A. S. ; Rosenkranz, Eliot ; Lytle, B. W. ; Taylor, P. C. ; Stewart, W. J. ; Loop, F. D. ; Cosgrove, D. M. / Mitral valve repair for bacterial endocarditis. In: Journal of Thoracic and Cardiovascular Surgery. 1992 ; Vol. 103, No. 1. pp. 124-129.
@article{93bf1b173d76456589bea25ffb326132,
title = "Mitral valve repair for bacterial endocarditis",
abstract = "Twenty-two patients with mitral insufficiency resulting from native valve endocarditis underwent mitral valve repair. Six patients had acute endocarditis with positive blood cultures and active valve infection. Sixteen patients were cured of active infection, but mitral insufficiency developed as a result of prior infection. Mean age was 48.5 ± 21.7 years; 13 (59{\%}) were male. Mean New York Heart Association functional class was 2.6 ± 1.2. Multiple valve lesions were present in 11 (50{\%}) patients. Valve abnormalities included leaflet perforation in 13 patients, chordal rupture or elongation in 14, vegetations in 5; and annular abscess in 1. In patients with acute endocarditis all macroscopically infected tissue was excised. Multiple techniques were required to achieve valve competence. Suture or patch closure of perforation was done in 14 patients, chordal shortening or transfer in 9, leaflet resection and closure in 4, leaflet resection with pericardial patching in 5, and annuloplasty in 15. Mitral valvuloplasty was combined with other procedures in 11 (50{\%}) patients. There were two (9{\%}) hospital deaths, both occurring in patients with healed endocarditis. There was one (9{\%}) death in a patient undergoing an isolated procedure and one (9{\%}) in a patient undergoing a combined procedure. Mean follow-up was 24 ± 16.8 months and was complete. Seventeen (85{\%}) were in New York Heart Association functional class I, and three (15{\%}) were in class II. There were no late deaths, reoperations, recurrent endocarditis, thromboembolic events, or other valve-related morbidity. We conclude that mitral valve repair for insufficiency resulting from bacterial endocarditis (1) is possible in acute and healed disease, (2) has a low operative mortality, and (3) has resulted in patients free of recurrent infection and valve-related morbidity and mortality. Mitral valve repair is an attractive alternate to valve replacement in bacterial endocarditis.",
author = "Hendren, {W. G.} and Morris, {A. S.} and Eliot Rosenkranz and Lytle, {B. W.} and Taylor, {P. C.} and Stewart, {W. J.} and Loop, {F. D.} and Cosgrove, {D. M.}",
year = "1992",
month = "1",
day = "1",
language = "English",
volume = "103",
pages = "124--129",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Mitral valve repair for bacterial endocarditis

AU - Hendren, W. G.

AU - Morris, A. S.

AU - Rosenkranz, Eliot

AU - Lytle, B. W.

AU - Taylor, P. C.

AU - Stewart, W. J.

AU - Loop, F. D.

AU - Cosgrove, D. M.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Twenty-two patients with mitral insufficiency resulting from native valve endocarditis underwent mitral valve repair. Six patients had acute endocarditis with positive blood cultures and active valve infection. Sixteen patients were cured of active infection, but mitral insufficiency developed as a result of prior infection. Mean age was 48.5 ± 21.7 years; 13 (59%) were male. Mean New York Heart Association functional class was 2.6 ± 1.2. Multiple valve lesions were present in 11 (50%) patients. Valve abnormalities included leaflet perforation in 13 patients, chordal rupture or elongation in 14, vegetations in 5; and annular abscess in 1. In patients with acute endocarditis all macroscopically infected tissue was excised. Multiple techniques were required to achieve valve competence. Suture or patch closure of perforation was done in 14 patients, chordal shortening or transfer in 9, leaflet resection and closure in 4, leaflet resection with pericardial patching in 5, and annuloplasty in 15. Mitral valvuloplasty was combined with other procedures in 11 (50%) patients. There were two (9%) hospital deaths, both occurring in patients with healed endocarditis. There was one (9%) death in a patient undergoing an isolated procedure and one (9%) in a patient undergoing a combined procedure. Mean follow-up was 24 ± 16.8 months and was complete. Seventeen (85%) were in New York Heart Association functional class I, and three (15%) were in class II. There were no late deaths, reoperations, recurrent endocarditis, thromboembolic events, or other valve-related morbidity. We conclude that mitral valve repair for insufficiency resulting from bacterial endocarditis (1) is possible in acute and healed disease, (2) has a low operative mortality, and (3) has resulted in patients free of recurrent infection and valve-related morbidity and mortality. Mitral valve repair is an attractive alternate to valve replacement in bacterial endocarditis.

AB - Twenty-two patients with mitral insufficiency resulting from native valve endocarditis underwent mitral valve repair. Six patients had acute endocarditis with positive blood cultures and active valve infection. Sixteen patients were cured of active infection, but mitral insufficiency developed as a result of prior infection. Mean age was 48.5 ± 21.7 years; 13 (59%) were male. Mean New York Heart Association functional class was 2.6 ± 1.2. Multiple valve lesions were present in 11 (50%) patients. Valve abnormalities included leaflet perforation in 13 patients, chordal rupture or elongation in 14, vegetations in 5; and annular abscess in 1. In patients with acute endocarditis all macroscopically infected tissue was excised. Multiple techniques were required to achieve valve competence. Suture or patch closure of perforation was done in 14 patients, chordal shortening or transfer in 9, leaflet resection and closure in 4, leaflet resection with pericardial patching in 5, and annuloplasty in 15. Mitral valvuloplasty was combined with other procedures in 11 (50%) patients. There were two (9%) hospital deaths, both occurring in patients with healed endocarditis. There was one (9%) death in a patient undergoing an isolated procedure and one (9%) in a patient undergoing a combined procedure. Mean follow-up was 24 ± 16.8 months and was complete. Seventeen (85%) were in New York Heart Association functional class I, and three (15%) were in class II. There were no late deaths, reoperations, recurrent endocarditis, thromboembolic events, or other valve-related morbidity. We conclude that mitral valve repair for insufficiency resulting from bacterial endocarditis (1) is possible in acute and healed disease, (2) has a low operative mortality, and (3) has resulted in patients free of recurrent infection and valve-related morbidity and mortality. Mitral valve repair is an attractive alternate to valve replacement in bacterial endocarditis.

UR - http://www.scopus.com/inward/record.url?scp=0026601711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026601711&partnerID=8YFLogxK

M3 - Article

C2 - 1728697

AN - SCOPUS:0026601711

VL - 103

SP - 124

EP - 129

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 1

ER -